A B S T R A C T Synthetic ovine corticotropin-releasing factor (CRF) was administered to normal male volunteer subjects as an intravenous bolus or 30-s infusion. Doses of CRF ranging from 0.001 to 30 sg/kg body wt were administered, and plasma immunoreactive (IR)-ACTH and IR-cortisol concentrations were measured. The threshold dose appeared to be 0.01-0.03 ag/kg, the half-maximal dose 0.3-1 sg/kg, and the maximally effective dose 3-10 ug/kg. Basal concentrations of IR-ACTH and IR-cortisol were 14±7.6 pg/ ml (mean±SD) and 5.6±2.2 gg/dl, respectively. IR-ACTH rose as early as 2 min after CRF injection, reached peak levels in 10-15 min, and declined slowly thereafter. IR-cortisol rose at 10 min or later and reached peak levels in 30-60 min. At a dose of 30 jig/ kg, neither IR-ACTH nor IR-cortisol fell from peak levels of 82±21 pg/ml (mean±SE) and 23±1.4 ,g/dl, respectively, during the 2-h course of the experiment, indicating that CRF has a sustained effect on ACTH release and/or a prolonged circulating plasma halflife. There was little or no increase in the levels of other anterior pituitary hormones. At doses of 1 gg/ Preliminary results of these studies were presented by Dr.